Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 1798285, 10 pages
http://dx.doi.org/10.1155/2016/1798285
Review Article

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis

1Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong 510060, China
2Department of Laboratory Medicine, Guangdong No. 2 Provincial People’s Hospital, Guangdong, China
3Department of General Surgery, People’s Hospital of Yuxi City, Yunnan, China
4Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, China
5Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong 510060, China

Received 2 April 2016; Accepted 30 June 2016

Academic Editor: Carlos Fernandez-Martos

Copyright © 2016 Guo-Chen Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. A. Rich, J. M. Skibber, J. A. Ajani et al., “Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 32, no. 4, pp. 1025–1029, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. N. A. Janjan, C. N. Crane, B. W. Feig et al., “Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 3, pp. 713–718, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. C. H. Crane, J. M. Skibber, E. H. Birnbaum et al., “The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 57, no. 1, pp. 84–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. O'Connell, J. A. Martenson, H. S. Wieand et al., “Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery,” The New England Journal of Medicine, vol. 331, no. 8, pp. 502–507, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. H. P. Kalofonos, A. Bamias, A. Koutras et al., “A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study,” European Journal of Cancer, vol. 44, no. 12, pp. 1693–1700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Di Carlo, E. Pulvirenti, M. Mannino, and A. Toro, “Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1649–1656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Mayer, “Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?” Journal of Clinical Oncology, vol. 25, no. 27, pp. 4165–4167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Van Cutsem, M. Findlay, B. Osterwalder et al., “Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study,” Journal of Clinical Oncology, vol. 18, no. 6, pp. 1337–1345, 2000. View at Google Scholar · View at Scopus
  10. P. M. Hoff, R. Ansari, G. Batist et al., “Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study,” Journal of Clinical Oncology, vol. 19, no. 8, pp. 2282–2292, 2001. View at Google Scholar · View at Scopus
  11. J. Dunst, T. Reese, T. Sutter et al., “Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer,” Journal of Clinical Oncology, vol. 20, no. 19, pp. 3983–3991, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. R.-D. Hofheinz, F. Wenz, S. Post et al., “Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial,” The Lancet Oncology, vol. 13, no. 6, pp. 579–588, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. O'Connell, L. H. Colangelo, R. W. Beart et al., “Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04,” Journal of Clinical Oncology, vol. 32, no. 18, pp. 1927–1934, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Chan, A. O. Wong, and D. A. Jenken, “Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer—is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?” International Journal of Radiation Oncology, Biology, Physics, vol. 76, no. 5, pp. 1413–1419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-F. Chen, M.-Y. Huang, C.-J. Huang et al., “A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer,” International Journal of Colorectal Disease, vol. 27, no. 6, pp. 727–736, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Das, E. H. Lin, S. Bhatia et al., “Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 5, pp. 1378–1383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Y. Kim, K. H. Jung, T. H. Kim et al., “Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 2, pp. 378–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-S. Kim, J.-S. Kim, M.-J. Cho, W.-H. Yoon, and K.-S. Song, “Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer,” Journal of Korean Medical Science, vol. 21, no. 1, pp. 52–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. V. S. Ramani, A. Sun Myint, A. Montazeri, and H. Wong, “Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine,” Colorectal Disease, vol. 12, no. 2, pp. 37–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Yerushalmi, E. Idelevich, Y. Dror et al., “Preoperative chemoradiation in rectal cancer: retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil,” Journal of Surgical Oncology, vol. 93, no. 7, pp. 529–533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. L. Demets, “Methods for combining randomized clinical trials: strengths and limitations,” Statistics in Medicine, vol. 6, no. 3, pp. 341–348, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” The British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Piedbois, P. Rougier, M. Buyse et al., “Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer,” Journal of Clinical Oncology, vol. 16, pp. 301–308, 1998. View at Google Scholar
  25. M. Maas, P. J. Nelemans, V. Valentini et al., “Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data,” The Lancet Oncology, vol. 11, no. 9, pp. 835–844, 2010. View at Publisher · View at Google Scholar · View at Scopus